SI-B003 + Izalontamab
1 treatment and condition followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| SI-B003 + Izalontamab for squamous cell carcinoma of head and neck | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |